Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations. Curr Breast Cancer Rep 2024 Jun;16(2):150-160
Date
06/27/2025Pubmed ID
40574868Pubmed Central ID
PMC12199283DOI
10.1007/s12609-024-00541-6Scopus ID
2-s2.0-85188604136 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of ten unique breast cancer subtypes and their clinicopathologic features and treatment implications.
RECENT FINDINGS: Recent findings show that while many subtypes (mucinous, papillary, tubular, apocrine) have favorable biology, with better overall survival than invasive ductal carcinoma, some (metaplastic, adenoid cystic) are more aggressive portending worse prognosis for patients.
SUMMARY: The differences in histology represented in these breast cancer subtypes often impacts biology, behavior, and prognosis. Due to their rarity, additional research is needed to implement clear treatment protocols for each subtype.
Author List
Cobb AN, Czaja R, Jorns J, Cortina CSAuthors
Adrienne Cobb MD Assistant Professor in the Surgery department at Medical College of WisconsinChandler S. Cortina MD Associate Professor in the Surgery department at Medical College of Wisconsin
Julie M. Jorns MD Professor in the Pathology and Laboratory Medicine department at Medical College of Wisconsin









